Search the Newsreel

Insperity Inc (NSP) Institutional Confidence

The article details Insperity Inc's (NSP) institutional confidence score, which is 10.00, placing it first in its industry. It highlights that the institutional shareholding proportion has increased by 9.15% quarter-over-quarter and identifies Chuck Royce as the largest institutional shareholder. The article also lists major …

AtriCure CEO Carrel joins Inspire Medical board of directors

Inspire Medical has appointed AtriCure CEO Michael Carrel to its board of directors, effective immediately. Carrel will also join the Organization and Compensation Committee and Quality, Product Supply and Technology Committee. Concurrently, Casey Tansey will retire from the board after 18 years, having been …

InspireMD Inc (NSPR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of InspireMD Inc (NSPR), listing its major shareholders and their respective proportions. It also provides a breakdown of shareholder types and institutional holdings over several quarters, along with recent changes in individual institutional holdings.

Insperity Inc (NSP) Cash Flow

This article provides a detailed historical cash flow statement for Insperity Inc (NSP), covering quarterly data for operating, investing, and financing activities. It presents financial figures and year-over-year percentage changes across various cash flow categories. The article also includes a FAQ section defining different …

Inspire Medical Systems, Inc. Revenue Breakdown – NYSE:INSP

Inspire Medical Systems, Inc. (INSP) generated $911.98 million in revenue last year, primarily from its Neurostimulation Technology segment. This marks an increase from $802.80 million in the previous year. The United States was the largest contributor to this revenue, accounting for $872.09 million.

InspireMD Inc (NSPR) Cash Flow

This article provides a detailed cash flow statement for InspireMD Inc (NSPR), presenting quarterly and annual data for operating, investing, and financing activities over several years. It includes key figures such as operating cash flow, net income from continuing operations, capital expenditures, and free …

Inspired Entertainment, Inc. Revenue Breakdown – NASDAQ:INSE

Inspired Entertainment, Inc. (NASDAQ:INSE) reported a total revenue of $304.10 million USD last year. Its top-performing segment, Gaming, contributed $112.30 million USD, an increase from the previous year. The United Kingdom was the largest regional contributor, generating $209.70 million USD in revenue for the …

Insperity, Inc. Revenue Breakdown – TRADEGATE:ASF

Insperity, Inc. (TRADEGATE: ASF) generated 5.80 billion EUR in revenue last year, primarily from its Human Resources and Business Solutions segment. This revenue was lower than the previous year's 6.36 billion EUR. The United States was the sole geographic contributor to this total.

Inspire Medical Systems (INSP) Refreshes Its Board, Is It Still Below Fair Value?

Inspire Medical Systems (INSP) has recently made board changes, with a new Class III director appointed and a long-serving director retiring. Despite a recent 13.87% share price return over 30 days, the stock has seen significant declines year-to-date and over the last year. However, …

INSE|Inspired Entertainment Inc|Price:6.900|Chg%:+0.260

This article provides a comprehensive stock analysis of Inspired Entertainment Inc (INSE) by TradingKey, highlighting its overall score, financial health, valuation, earnings forecast, price momentum, institutional confidence, and risk assessment. The company's fundamentals are stable with high growth potential, and its valuation is deemed …

Inspired Entertainment Market Sentiment

This article provides an overview of market sentiment for Inspired Entertainment (INSE), detailing analyst consensus, short interest, options flow, and insider activity. Analysts have a "Market Outperform" consensus with an average price target of $15, indicating a significant upside. The short interest is declining, …

InspireMD Inc. Revenue Breakdown – NASDAQ:NSPR

InspireMD Inc. (NASDAQ: NSPR) generated $8.98 million USD in revenue last year, primarily from its CGuard Carotid Embolic Prevention System segment, which also brought in $8.98 million USD. The company's "Other" segment contributed $4.06 million USD to its revenue. This indicates a significant portion …

Inspire Medical Systems, Inc. Revenue Breakdown – BOATS:INSP

Inspire Medical Systems, Inc. (INSP) generated $911.98 million in revenue last year, primarily from its Neurostimulation Technology segment. This marks an increase from $802.80 million in the previous year. The United States was the largest contributor to this revenue, accounting for $872.09 million.

Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Kahn Swick & Foti, LLC (KSF) is continuing its investigation into Inspire Medical Systems, Inc. (NYSE: INSP) due to alleged breaches of fiduciary duties by its officers and directors. This follows disclosures in August 2025 regarding unforeseen issues with the Inspire V device launch, …

InspireMD Receives Nasdaq Minimum Bid Price Warning

InspireMD Inc. announced it has received a warning from Nasdaq regarding non-compliance with the minimum bid price rule. The company now has a 180-day grace period, until January 20, 2027, to regain compliance by having its common stock close at $1.00 or more for …

INSP|Inspire Medical Systems Inc|Price:50.760|Chg%:+0.360

Inspire Medical Systems Inc. (INSP) has strong fundamentals and high growth potential, though its valuation is considered fairly valued within the Healthcare Equipment & Supplies industry. Institutional ownership is very high, and analysts currently rate the stock as "Hold" with a target price of …

Insperity (NSP) Rebound Keeps Focus On Its Earnings Recovery Story As Undervalued View Builds

Earnings Preview: Insperity to Report Financial Results Post-market on July 29

Insperity (NSP) is scheduled to announce its financial results post-market on July 29. Analysts are forecasting earnings per share of $1.52, aligning with the previous year's earnings for the same quarter. Revenue expectations are set at $1.53 billion, which would represent a 1.25% increase …

InspireMD Inc (NSPR) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for InspireMD Inc (NSPR), noting its current valuation score is 7.68, ranking 136 out of 200 in its industry. It highlights the company's P/E ratio of -0.99, which is significantly below its recent high and above its recent …

InspireMD Disclosed Failure to Satisfy a Continued Listing Rule or Standard

InspireMD (NSPR) received a notice from Nasdaq on July 17, 2026, indicating its failure to meet the minimum bid price requirement of $1.00 for 30 consecutive business days. The company has 180 days, until January 13, 2027, to regain compliance while its stock continues …

InspireMD (NSPR) warned by Nasdaq over $1.00 bid price and delisting risk

InspireMD, Inc. (NSPR) received a notice from Nasdaq on July 17, 2026, indicating non-compliance with the minimum $1.00 bid price requirement. The company has 180 calendar days, until January 13, 2027, to regain compliance by achieving a closing bid price of at least $1.00 …

InspireMD gets Nasdaq notice for failing $1 minimum bid price rule

InspireMD (NSPR) received a Nasdaq notice on July 17, 2026, for failing to maintain the minimum $1 bid price, based on closing prices from June 3 to July 16. The company has until January 13, 2027, to regain compliance by achieving a $1 or …

Insperity, Inc. (NSP) Stock forecasts

Argus has raised its target price for Insperity, Inc. (NSP) to $43.00 as of July 1, 2026. Insperity is described as a company providing human resources and business solutions to improve business performance. The current price for NSP is $48.35.

After more than 18 years, Casey Tansey to retire from Inspire board

Inspire Medical Systems (NYSE: INSP) announced that Casey M. Tansey will retire from its Board of Directors on July 30 after over 18 years, having led the company's Series A financing in 2007. The company's CEO, Tim Herbert, expressed gratitude for Tansey's significant contributions …

Truist Raises Price Target on Insperity to $52 From $35, Keeps Hold Rating

Truist has increased its price target for Insperity (NYSE: NSP) to $52, up from the previous $35, while maintaining a "Hold" rating on the stock. This adjustment comes despite several recent news items for Insperity, including its drop from certain Russell indices and quarterly …

Inspire Medical Systems (INSP) Q4 2024 earnings summary

Inspire Medical Systems (INSP) achieved its first full year of profitability in 2024, with revenue reaching $802.8M–$803M, a 28% increase. The company expanded its U.S. medical centers and sales territories, launched new digital tools, and received FDA approval for Inspire 5 and EU MDR …

Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors

Inspire Medical Systems, Inc. announced the retirement of Casey M. Tansey from its Board of Directors, effective July 30, after more than eighteen years of service. Mr. Tansey played a pivotal role as one of the first venture investors in Inspire and provided significant …

Inspired Entertainment schedules an 8 a.m. ET webcast for Aug. 6

Inspired Entertainment (NASDAQ: INSE) announced it will report its second-quarter 2026 financial results on Thursday, August 6, 2026, before market open. Management will host a conference call and webcast at 8:00 a.m. ET (1:00 p.m. UK) to discuss the results. Investors and analysts can …

Inspired Entertainment (NASDAQ:INSE) Trading 3.4% Higher - What's Next?

Inspired Entertainment to report Q2FY26 results on August 6

Inspired Entertainment, Inc. announced it will release its Q2FY26 financial results on August 6, 2026, before market open, with a conference call and webcast scheduled for 8:00 a.m. ET to discuss the quarterly performance. The company, a B2B provider of gaming content and technology, …

Inspired to Report Second Quarter 2026 Results and Hold Conference Call on August 6th

Inspired Entertainment, Inc. (NASDAQ: INSE) announced that it will report its financial results for the second quarter ended June 30, 2026, before the market opens on Thursday, August 6, 2026. The company will also host a conference call and simultaneous webcast on the same …

Insperity Inc (NSP) Shares Surge 4.3% -- What GF Score of 64 Tells Investors

Insperity Inc (NSP) shares surged 4.3% to $51.70, indicating it is significantly undervalued by 43.2% based on its GF Value™ of $91.03. The company holds a GF Score™ of 64/100, reflecting above-average quality, particularly in profitability (7/10), despite concerns about its momentum (1/10) and …

3 Medical Device Stocks Giving Investors a Different Healthcare Play

This article highlights three medical device companies—Globus Medical (GMED), Inspire Medical Systems (INSP), and Penumbra (PEN)—as appealing alternatives to traditional pharmaceutical investments. Globus Medical shows strong revenue growth through spinal disorder treatments and new product clearances, while Inspire Medical Systems, despite short-term headwinds from …

The Technical Signals Behind (INSE) That Institutions Follow

This article analyzes the technical signals for Inspired Entertainment Inc. (NASDAQ: INSE), highlighting weak sentiment across all horizons supporting a short bias. It identifies a mid-channel oscillation pattern and an exceptional 57.5:1 risk-reward setup targeting an 18.6% gain versus 0.3% risk. The report also …

Price to earnings forward of Inspire Medical Systems, Inc. – NYSE:INSP

This article provides the "Price to earnings forward" metric for Inspire Medical Systems, Inc. (NYSE:INSP) as part of its financial data overview. It specifies the period, value, and change for this financial indicator, noting that the data is presented by FactSet. The page itself …

Inspire Medical (NYSE: INSP) grants 346 shares to director Tansey

Inspire Medical Systems director Casey M. Tansey was granted 346 shares of common stock on July 15, 2026, as compensation in lieu of cash fees, with a reported price of $0.00 per share. After this transaction, Tansey directly holds 26,632 shares and indirectly holds …